Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

PARP inhibitors for prostate cancer: What oncology PAs should know

Colleen Tetzlaf, PA-C, Fox Chase Cancer Center, Philadelphia, USA
PARP inhibitors for prostate cancer: What oncology PAs should know ( Colleen Tetzlaf, PA-C, Fox Chase Cancer Center, Philadelphia, USA )
18 Dec 2020

APAO: Current initiatives and hopes for the future

Colleen Tetzlaf, PA-C - APAO President
APAO: Current initiatives and hopes for the future ( Colleen Tetzlaf, PA-C - APAO President )
18 Dec 2020

How COVID-19 has impacted oncology nursing practice and guidelines

Kathleen Wiley - Director of Oncology Nursing Practice, ONS
How COVID-19 has impacted oncology nursing practice and guidelines ( Kathleen Wiley - Director of Oncology Nursing Practice, ONS )
18 Dec 2020

Big data, machine learning and drug discovery in oncology

Prof Bissan Al-Lazikani - Institute of Cancer Research, London, UK
Big data, machine learning and drug discovery in oncology ( Prof Bissan Al-Lazikani -  Institute of Cancer Research, London, UK )
18 Dec 2020

ESMO 2020: New developments in the treatment of lung cancer

Dr Luis Raez - Memorial Cancer Institute, Miami, USA
ESMO 2020: New developments in the treatment of lung cancer ( Dr Luis Raez - Memorial Cancer Institute, Miami, USA )
17 Dec 2020

SABCS 2020: Conference roundup

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
SABCS 2020: Conference roundup ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
16 Dec 2020

PRWCC: Disease burden impacts outcomes in paediatric and young adult B-Cell ALL after commercial tisagenlecleucel

Dr Liora Schultz - Stanford University School of Medicine, Palo Alto, USA
PRWCC: Disease burden impacts outcomes in paediatric and young adult B-Cell ALL after commercial tisagenlecleucel ( Dr Liora Schultz - Stanford University School of Medicine, Palo Alto, USA )
16 Dec 2020

Researchers trace the origin of blood cancer to early childhood, decades before diagnosis

Dr Jyoti Nangalia - University of Cambridge, Cambridge, UK
Researchers trace the origin of blood cancer to early childhood, decades before diagnosis ( Dr Jyoti Nangalia - University of Cambridge, Cambridge, UK )
16 Dec 2020

Risk profiling of relapsed/refractory diffuse large B-cell lymphoma patients by measuring circulating tumour DNA

Dr Alex Herrera - City of Hope Comprehensive Cancer Center, Duarte, USA
Risk profiling of relapsed/refractory diffuse large B-cell lymphoma patients by measuring circulating tumour DNA ( Dr Alex Herrera - City of Hope Comprehensive Cancer Center, Duarte, USA )
15 Dec 2020

ASH 2020: Immunotherapy in relapsed/refractory multiple myeloma

Dr Robert Rifkin, Prof Sagar Lonial, Prof Evangelos Terpos, Dr Nina Shah, Dr Eric Smith
ASH 2020:  Immunotherapy in relapsed/refractory multiple myeloma ( Dr Robert Rifkin, Prof Sagar Lonial, Prof Evangelos Terpos, Dr Nina Shah, Dr Eric Smith )
15 Dec 2020

Survival analysis of newly diagnosed transplant-eligible multiple myeloma patients in the randomised Forte trial

Dr Francesca Gay - University of Torino, Torino, Italy
Survival analysis of newly diagnosed transplant-eligible multiple myeloma patients in the randomised Forte trial ( Dr Francesca Gay - University of Torino, Torino, Italy )
14 Dec 2020

Circulating tumour cell dynamics as a predictor for treatment response and prognosis in metastatic breast cancer patients

Prof Wolfgang Janni - Ulm University, Ulm, Germany
Circulating tumour cell dynamics as a predictor for treatment response and prognosis in metastatic breast cancer patients ( Prof Wolfgang Janni - Ulm University, Ulm, Germany )
11 Dec 2020